Video

Antivirals for Treating Influenza

Edina Avdic, PharmD, MBA, BCPS-AQ ID, associate director, Antimicrobial Stewardship Program, The Johns Hopkins Hospital in Baltimore, Maryland, discusses current antiviral treatments for influenza. This video was filmed at the ASHP (American Society of Health-System Pharmacists) 54th Clinical Meeting & Exhibition in Las Vegas, Nevada.

Edina Avdic, PharmD, MBA, BCPS-AQ ID, associate director, Antimicrobial Stewardship Program, The Johns Hopkins Hospital in Baltimore, Maryland, discusses current antiviral treatments for influenza. This video was filmed at the ASHP (American Society of Health-System Pharmacists) 54th Clinical Meeting & Exhibition in Las Vegas, Nevada.

Edina Avdic, PharmD, MBA, BCPS-AQ ID: What are the current antiviral agents that are available for treatment of influenza? Well, there are only 2 classes of agents that are currently available: those are neuraminidase inhibitors which have been in the market for quite some time, and we have 3 agents in this class. So that’s oseltamivir (Tamiflu) that’s available orally only; zanamivir (Relenza), which is an inhaler; and peramivir (Rapivab), which is available as an IV. Last year, in October, a new agent was approved: baloxavir marboxil (Xofluza) that has a novel mechanism of action, and that’s available currently only in oral form.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
Image credit: Sebastian Kaulitzki | stock.adobe.com
Magnified bone marrow biopsy showing plasma cells with irregular nuclei and multiple myeloma tumor cells infiltrating normal hematopoietic tissue.